Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.65x is 89% above its 5-year average of -15.14x, near the high end of its 5-year range (-35.93x–-0.03x).
30.35% below its 12-month average of -1.27x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.75x.
INTEREST COVERAGE RATIO
-1.65x
INTEREST COVERAGE RATIO AVG TTM
-1.27x
INTEREST COVERAGE RATIO AVG 3Y
-9.97x
INTEREST COVERAGE RATIO AVG 5Y
-15.14x
INTEREST COVERAGE RATIO AVG 10Y
-16.86x
INTEREST COVERAGE RATIO AVG 15Y
-275.93x
INTEREST COVERAGE RATIO AVG 20Y
-369.59x
CURRENT VS TTM AVG
-30.35%
CURRENT VS 3Y AVG
+83.44%
CURRENT VS 5Y AVG
+89.10%
CURRENT VS 10Y AVG
+90.22%
CURRENT VS 15Y AVG
+99.40%
CURRENT VS 20Y AVG
+99.55%
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
+60.99%
vs the sector median at left
Geron Corporation
Market Cap
$769.83M
Interest Coverage Ratio
-1.65x
TTM Avg
-1.27x
3Y Avg
-9.97x
5Y Avg
-15.14x
Market Cap
$762.81M
Interest Coverage Ratio
-85.20x
TTM Avg
23.14x
3Y Avg
23.14x
5Y Avg
23.14x
Market Cap
$777.34M
Interest Coverage Ratio
-5.87x
TTM Avg
6.84x
3Y Avg
6.84x
5Y Avg
3.53x
Market Cap
$764.21M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$787.62M
Interest Coverage Ratio
1.73x
TTM Avg
1.55x
3Y Avg
1.27x
5Y Avg
1.31x
Market Cap
$745.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$798.22M
Interest Coverage Ratio
1.76x
TTM Avg
1.92x
3Y Avg
1.86x
5Y Avg
1.93x
Market Cap
$740.03M
Interest Coverage Ratio
-22.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $769.83M | -1.65x | -1.27x | -9.97x | -15.14x |
| Cytek Biosciences, Inc. (CTKB)vs › | $762.81M | -85.20x | 23.14x | 23.14x | 23.14x |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -5.87x | 6.84x | 6.84x | 3.53x |
| Attovia Therapeutics, Inc. (ATTO)vs › | $764.21M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $787.62M | 1.73x | 1.55x | 1.27x | 1.31x |
| Design Therapeutics, Inc. (DSGN)vs › | $745.42M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $798.22M | 1.76x | 1.92x | 1.86x | 1.93x |
| Candel Therapeutics, Inc. (CADL)vs › | $740.03M | -22.78x | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $809.62M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $719.62M | N/A | 578.36x | 578.36x | 578.36x |
Interest Coverage
-1.6x
Debt/Equity
0.56
Current Ratio
6.92
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.75x |
| 2026-03-31 | -0.03x |
| 2025-12-31 | -1.48x |
| 2025-09-30 | -1.61x |
| 2025-06-30 | -1.46x |
| 2025-03-31 | -2.04x |
| 2024-12-31 | -2.30x |
| 2024-09-30 | -9.26x |
| 2024-06-30 | -20.89x |
| 2024-03-31 | -16.35x |
| 2023-12-31 | -23.39x |
| 2023-09-30 | -23.05x |
| 2023-06-30 | -25.94x |
| 2023-03-31 | -20.86x |
| 2022-12-31 | -20.92x |
| 2022-09-30 | -21.99x |
| 2022-06-30 | -17.70x |
| 2022-03-31 | -19.39x |
| 2021-12-31 | -27.30x |
| 2021-09-30 | -24.27x |
| 2021-06-30 | -35.93x |
| 2021-03-31 | -38.30x |
| 2020-12-31 | -31.65x |
| 2020-09-30 | -3335.83x |
| 2019-09-30 | -469.76x |
| 2017-12-31 | -432.56x |
| 2017-03-31 | -356.86x |
| 2016-12-31 | -399.14x |
| 2016-09-30 | -184.62x |
| 2016-06-30 | -469.00x |
| 2016-03-31 | -432.24x |
| 2015-12-31 | -432.20x |
| 2015-09-30 | 1228.18x |
| 2015-06-30 | -430.86x |
| 2015-03-31 | -394.00x |
| 2014-12-31 | -429.10x |
| 2014-09-30 | -450.32x |
| 2014-06-30 | -376.65x |
| 2014-03-31 | -545.69x |
| 2013-12-31 | -772.92x |
| 2013-09-30 | -727.75x |
| 2013-06-30 | -640.36x |
| 2013-03-31 | -665.83x |
| 2012-12-31 | -1026.89x |
| 2012-09-30 | -92.31x |
| 2012-06-30 | -923.95x |
| 2012-03-31 | -822.52x |
| 2011-12-31 | -515.39x |
| 2011-09-30 | -174.88x |
| 2011-06-30 | -690.84x |
| 2011-03-31 | -738.06x |
| 2010-12-31 | -2709.59x |
| 2010-09-30 | -758.46x |
| 2010-06-30 | -675.04x |
| 2010-03-31 | -610.26x |
| 2009-12-31 | -680.44x |
| 2009-09-30 | -546.67x |
| 2009-06-30 | -551.68x |
| 2009-03-31 | -321.25x |
| 2008-12-31 | -1031.95x |
| 2008-09-30 | -779.74x |
| 2008-06-30 | -644.08x |
| 2008-03-31 | -664.54x |
| 2007-12-31 | -597.33x |
| 2007-09-30 | -638.96x |
| 2007-06-30 | -644.85x |
| 2006-12-31 | -499.85x |
| 2006-09-30 | -465.15x |
| 2006-06-30 | -300.21x |
| 2006-03-31 | -271.55x |
| 2005-12-31 | -140.39x |
| 2005-06-30 | -22.79x |
| 2005-03-31 | -60.25x |
| 2004-12-31 | -58.37x |
| 2004-06-30 | -56.59x |
| 2004-03-31 | -305.95x |
| 2003-12-31 | -49.98x |
| 2003-09-30 | -33.36x |
| 2002-12-31 | -44.40x |
| 2002-09-30 | -39.59x |
